First pharmacological guideline for obesity treatment provides clinical roadmap for anti-obesity drug treatment

The first-ever clinical practice guideline for the drug treatment of obesity offers a new tool for health practitioners looking to the latest pharmacotherapy strategies as a means of treating patients with obesity. The release comes on the heels of U.S. Food and Drug Administration (FDA) approval of four new anti-obesity drugs in the past two […]

Continue Reading